Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) announced Friday positive early-stage data for REGN1979 in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL).
from RTT - Biotech http://bit.ly/31zmBbR
via IFTTT
No comments:
Post a Comment